Skip to main content
. 2021 Jun 3;11:11818. doi: 10.1038/s41598-021-91307-y

Figure 3.

Figure 3

Persistent knockout of endogenous TCR in primary human T cells with Cas9 and µVS. Cas9 and locus-specific TRAC-1 gRNAs (as Cas9–RNP complexes) were delivered to activated primary human CD3+ T cells via µVS or electroporation. Quantification of (A) percentage of TCR knockout cells, (B) total viable, TCR knockout cells, (C) percentage of viable T cells and (D) total viable T cells were performed at Days 1, 4, 7, 10 and 14 post-transfection. TCR expression was measured via CD3 and TCRα/β co-staining. TCR knockout was quantified as a percentage of CD3- and TCRα/β-double negative cells and the total number of live cells. Propidium iodide exclusion gating and event collection rate were used to measure viability and cell concentration, respectively. Non-targeting gRNA as a Cas9–RNP complex served as a non-editing control. Non-transfected samples served as a negative control. Data represents mean ± SD of n = 3 samples per condition and ≥ 2 independent experiments. *P < 0.05, **P < 0.01 by unpaired, two-tailed, heteroscedastic t tests. Figure generated using Adobe Illustrator Creative Cloud (adobe.com/products/illustrator.html) and GraphPad Prism 9 (graphpad.com/scientific-software/prism/).